ERK1/2 inhibitor 9 is a covalent ERK1/2 inhibitor with sub-micromolar cellular activity (A375 GI50 = 0.47 μM); it downregulates phosphorylated ERK1/2 and, upon trans-cyclooctene (TCO) tagging, reacts with Tz-Thalidomide to form an ERK-CLIPTAC, thereby inducing degradation of ERK1/2.